Vella V - Search Results

1

IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.

Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A. Matà R, et al. Among authors: vella v. Oncotarget. 2016 Feb 16;7(7):7683-700. doi: 10.18632/oncotarget.6524. Oncotarget. 2016. PMID: 26655502 Free PMC article.

2

Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.

Belfiore A, Pandini G, Vella V, Squatrito S, Vigneri R. Belfiore A, et al. Among authors: vella v. Biochimie. 1999 Apr;81(4):403-7. doi: 10.1016/s0300-9084(99)80088-1. Biochimie. 1999. PMID: 10401676

3

The IGF system in thyroid cancer: new concepts.

Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, Belfiore A. Vella V, et al. Mol Pathol. 2001 Jun;54(3):121-4. doi: 10.1136/mp.54.3.121. Mol Pathol. 2001. PMID: 11376121 Free PMC article. Review.

4

Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy.

Ippolito A, Vella V, La Rosa GL, Pellegriti G, Vigneri R, Belfiore A. Ippolito A, et al. Among authors: vella v. Thyroid. 2001 Aug;11(8):783-7. doi: 10.1089/10507250152484646. Thyroid. 2001. PMID: 11525273

5

A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.

Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V, Belfiore A. Vella V, et al. J Clin Endocrinol Metab. 2002 Jan;87(1):245-54. doi: 10.1210/jcem.87.1.8142. J Clin Endocrinol Metab. 2002. PMID: 11788654

6

Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease.

Vella V, Mineo R, Frasca F, Mazzon E, Pandini G, Vigneri R, Belfiore A. Vella V, et al. J Clin Endocrinol Metab. 2004 Jun;89(6):2880-9. doi: 10.1210/jc.2003-031639. J Clin Endocrinol Metab. 2004. PMID: 15181072

7

The p53-homologue p63 may promote thyroid cancer progression.

Malaguarnera R, Mandarino A, Mazzon E, Vella V, Gangemi P, Vancheri C, Vigneri P, Aloisi A, Vigneri R, Frasca F. Malaguarnera R, et al. Among authors: vella v. Endocr Relat Cancer. 2005 Dec;12(4):953-71. doi: 10.1677/erc.1.00968. Endocr Relat Cancer. 2005. PMID: 16322335

8

p53 family proteins in thyroid cancer.

Malaguarnera R, Vella V, Vigneri R, Frasca F. Malaguarnera R, et al. Among authors: vella v. Endocr Relat Cancer. 2007 Mar;14(1):43-60. doi: 10.1677/erc.1.01223. Endocr Relat Cancer. 2007. PMID: 17395974 Review.

9

TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.

Malaguarnera R, Vella V, Pandini G, Sanfilippo M, Pezzino V, Vigneri R, Frasca F. Malaguarnera R, et al. Among authors: vella v. Mol Cancer Res. 2008 Jan;6(1):64-77. doi: 10.1158/1541-7786.MCR-07-0005. Mol Cancer Res. 2008. PMID: 18234963

10

BRAF(V600E) mutation and the biology of papillary thyroid cancer.

Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R. Frasca F, et al. Among authors: vella v. Endocr Relat Cancer. 2008 Mar;15(1):191-205. doi: 10.1677/ERC-07-0212. Endocr Relat Cancer. 2008. PMID: 18310287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page